Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Evofem Biosciences Inc (ID) EVFM

Healthcare Biotechnology
Evofem Biosciences, Inc., a biopharmaceutical company, develops and commercializes various products to address unmet needs in women’s sexual and reproductive health. The company’s commercial products include PHEXXI, a vaginal gel for the prevention of pregnancy; and SOLOSEC, a single-dose oral antimicrobial agent for the treatment of bacterial vaginosis and trichomoniasis. Evofem Biosciences, Inc. is headquartered in San Diego, California.


OTCID:EVFM - Post by User

Evofem Biosciences Inc (ID)
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(476)
•••
  • IseneschalX
Post by Iseneschalon Dec 12, 2023 10:32am
75 Views
Post# 35779840

EVFM..... A break of ~ $0.25 would be very positive ; )

EVFM..... A break of ~ $0.25 would be very positive ; )
Just watching....no position
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities